United States Securities and Exchange Commission · EDGAR Accession 0001870611-26-000005

Form C-AR

Annual Report — Regulation Crowdfunding
Campaign file 020-33478
Issuer CIK 1870611
Period 2025-12-31

Pirouette Pharma Inc

CorporationDEIncorporated 2017Portsmouth, NHpirouettepharma.com
B

Financial Condition

two fiscal years, as filed
Pre-revenueBurn increasingDebt / assets 314%17 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(5,360,471)(4,050,003)▼ burn
Total assets4,374,4373,878,452▲ 13%
Cash & equivalents2,076,6401,610,924▲ 29%
Accounts receivable00
Short-term debt501,599497,330▲ 1%
Long-term debt13,241,0557,388,869▲ 79%
Taxes paid00

Figures in USD as reported by the issuer.

C

Campaign Timeline

file 020-33478 · all filings under this campaign
Loading campaign history…